App-Quantinova.ai

The Value of Core Lab Stress Echocardiography Interpretations: Observations From the ISCHEMIA Trial

Marielle Scherrer-Crosbie - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Transient Ischemic Dilatation During Stress Echocardiography: A Marker of Significant Myocardial Ischemia

Marielle Scherrer-Crosbie - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Modifying the Seattle Heart Failure Model Improves Survival Prediction in Heart Failure Patients

Sylvie A. Ahn - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Congestive heart failure

N/A

Lysine Acetylation Enhances Cardiac Fatty Acid ?-Oxidation

Sowndramalingam Sankaralingam - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Congestive heart failure

N/A

Angiotensin 1-7 Ameliorates Diabetic Cardiomyopathy in db/db Mice by Reducing Lipotoxicity: A Critical Role for Adipose Triglyceride Lipase

Vaibhav B Patel - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic cardiomyopathy

Angiotensin II

Does T-type Calcium Channel Blockade Protect against Atrial Fibrillation Related Remodeling?

Yuki Iwasaki - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Mibefradil

Comparative Assessment of Exogenous and Endogenous Cardiac Repair Using an Injectable Porcine Submucosa-Extracellular Matrix in a Myocardial Scar Model

Hadi Toeg - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Chronic Allograft Vasculopathy is Promoted by Increased Mitochondrial Activity

Xiaoqin Hua - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

N/A

Clopidogrel bisulfate

Oxidative Stress Independently Predicts Diastolic Dysfunction in Women With Signs and Symptoms of Ischemia Without Obstructive Coronary Artery Disease: Results From the NHLBI-Sponsored Women Ischemia Syndrome Evaluation (WISE) Study

Puja K Mehta - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Coronary Artery Disease

glutathione

Effect of Delays in Treatment on Outcome in Young Women and Men With ST-Elevation Myocardial Infarction: Results From the PRAXY Study

Karin H Humphries - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

N/A

A Double-Blind Randomized Controlled Trial Comparing the Effectiveness of External Loop Monitor and Automatic Real Time Continuous Tele-ecg Cardiac Monitor in Detecting Atrial Fibrillation Among Patients With Tia: A Pilot Study

Maher El-Masri - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

N/A

Tricuspid Regurgitation is Associated to Higher Mortality in Patients With Low-Flow Low-Gradient Aortic Stenosis and Low Ejection Fraction -Results From the TOPAS Study-

Marie-Annick Clavel - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Tricuspid regurgitation

N/A

QRS Complex Duration Predicts Outcome in Children With Pulmonary Hypertensive Vascular Disease

Elven Guo - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Pulmonary arterial hypertension

N/A

Outcomes in Women Compared With Men in Patients With Unstable Angina/Non-ST-Segment Elevation Myocardial Infarction Managed Without Revascularization: Insights From the TRILOGY ACS Trial

Peter Clemmensen - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

Clopidogrel bisulfate

Patients With Isolated Cardiac Sarcoidosis and Implantable Cardiac Defibrillators Have High Rates of Ventricular Arrhythmias

William H Sauer - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Left anterior fascicular block

N/A

Gender Differences in Microvascular Vasomotor Response to Mental Stress in Patients With Stable Coronary Artery Disease

David Sheps - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Stable coronary artery disease

sestamibi

Antidepressant Use is Associated With Reduced Cardiovascular Reactivity and Myocardial Ischemia During Mental Stress

David Sheps - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

sestamibi

Impact of Diastolic Dysfunction on Outcome in Patients With Low-Flow, Low-Gradient and Low Ejection Fraction Aortic Stenosis -Results From the TOPAS Study-

Marie-Annick Clavel - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Diastolic dysfunction

EF-40

Ventricular Assist Device (VAD) Support as a Bridge To Pediatric Heart Transplantation: A Practice In Rapid Evolution

David C Naftel - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congenital heart disease

N/A

5-Lipoxygenase Inhibitor VIA-2291 (Atreleuton) Treatment Decreases Epicardial and Pericardial Adipose Tissue in Patients with Recent Acute Coronary Syndrome

Vahid Nabavi Larijani - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

Atreleuton

Filters

28841 Abstracts